Oct. 30 at 7:05 PM
⌛️⏳️ Potential swing ideas 💡
✅️
$CLRB small float, recently received rare pediatric drug designation (RPDD) for iopofosine |131 in inoperable relapsed or refractory pediatric high-grade glioma, recently submitted CMA apllication for iopososine |131 expected early 2026, company focuses on developing targeted cancer therapies using proprietary Phospholipid drug conjugate (PDC) platform, pipeline include iopososine }131, aimed at delivering a radioactive isotope )iodine-131) directly into cancer cells, company also developing treatment for disease wigh high unmet need Roth Capital price target
$18,
✅️
$INEO recently awarded multi-million dollar contract from PSA Singapore, recently signed collaboration with HyCee to develop, deploy hydrogen-related technologies and infrastructure in Singapore , back to consolidation from recent high, company focuses on cloud-based IoT to retail analytics and advertising services targeting retailers and brands
